Sitemap
October 08, 2016 Articles
Filter by Available Specialty
- Adjuvant ipilimumab extends survival in stage III melanoma
- Alisertib may benefit certain patients with neuroendocrine prostate cancer
- Alternative therapies for PDR considered
- Debate focuses on appropriateness of cangrelor, pretreatment with oral antiplatelets in patients undergoing PCI
- Fulvestrant extends PFS in certain postmenopausal women with breast cancer
- Greater likelihood of healing seen with antibiotic-loaded collagen granules as dressing agent vs EUSOL
- Insulin resistance may begin with sugar consumption
- NIH Common Fund awards $127 million for biomedical research
- Niraparib prolongs PFS in recurrent ovarian cancer
- Novel agent crosses blood-brain barrier to treat CNS metastases from breast cancer
- Olaparib fails to extend OS in advanced gastric cancer
- Plate fixation for clavicular fractures reduced risk of nonunion, but led to various complications
- Ribociclib plus letrozole extends PFS in hormone receptor–positive, HER-2–negative advanced breast cancer